Skip to main content
MedicineWatch US
Explore records
Trends
Coverage
About
Methodology
Report an issue
Privacy
Class III Recall
Esperion
Product
Nexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Manufactured for: Esperion Therapeutics, Inc, Ann Arbor, MI 48108, NDC 72426-818-03
Reason
Failed dissolution specifications: below specification results at stability 12-month
Classification
Class III
Status
Completed
Lot
Lot# 1904872, Exp 1/31/2025; 1950377, Exp 6/30/2025
Date
2023-09-13
Disclaimer:
This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.